Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
GlobalFoundries Reports Fourth Quarter 2025 and Fiscal Year 2025 Financial Results
-
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
-
Kelly Appoints Patrick McCall as Chief Growth Officer
-
Abaxx Broadens European Wind Futures Coverage with Enwex Netherlands, France and Spain Futures Contracts
-
Troilus Strengthens Financial Leadership as Project Advances Towards Construction
-
Dmitry Shubov On Navigating U.S. AI Rules: What Southeast Asian Legal-Tech Startups Must Do Before Entering the American Market
-
Aerodigm Wealth Becomes Independent Advisor to Ultra-High-Net-Worth Individuals and Families
-
ApplyBoard Research Team Wins Best Paper Award at IEEE International Conference for Breakthrough in AI Safety
-
abercrombie kids Launches Baby & Toddler Collection, Expanding its Offerings to Include Newborn to 5T Sizes
-
Baker Hughes Receives Gas Turbine Order from Twenty20 Energy to Power U.S. Data Center Infrastructure
-
Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award
-
Wellgistics Health to Add Telehealth & Mental Health AI Capabilities via Tollo Health Partnership Expansion
-
Municipality Finance Plc Financial Statements Bulletin 1 January–31 December 2025
-
White Gold Corp. Announces Spin-Out to Create a Yukon Focused Publicly Listed Critical Minerals Exploration Company
-
Savvly Appoints Securities Lawyer Rob Evans as General Counsel as it Advances Regulatory Approvals for Longevity-Based Investment Products
-
Your Clients, Your Brand: Zoe Financial Puts RIA Firms Front and Center with Private Labeling Feature
-
Azarga Metals Closes Non-Brokered Private Placement
-
North Shore Uranium Engages Resource Stock Digest
-
Industrial Supplier Strengthens eCommerce Performance with HawkSearch
-
abercrombie kids Launches Baby & Toddler Collection, Expanding its Offerings to Include Newborn to 5T Sizes
-
Dana to Pay Increased Dividend on Common Stock; Increases, Extends Share Repurchase Program
-
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
-
PENSKE AUTOMOTIVE GROUP REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
-
SourceDay Hits $5B Quarterly Spend Run Rate as Adoption Accelerates
-
Martin Marietta Reports Fourth-Quarter and Full-Year 2025 Results
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Jimmie Johnson Unveils "Helmet of Heroes" Tribute at DAYTONA 500 Honoring Fallen Firefighters in Partnership with Pye-Barker Fire & Safety, Driving Carvana No. 84
-
Ryder Reports Fourth Quarter 2025 Results and Provides 2026 Outlook
-
AECOM to provide detailed design services to support delivery of Sydney Metro West
-
GCT Semiconductor Partners with Skylo to Accelerate Global Satellite Connectivity
-
Crown Crafts Announces Financial Results for Third Quarter Fiscal 2026
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PINEWOOD TECHNOLOGIES GROUP - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JUST GROUP PLC - Ordinary Shares
-
CHIMERA INVESTMENT CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 EARNINGS
-
Tradr Unveils Short Leveraged ETFs on Bloom Energy and Nuscale Power
-
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
-
KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant O
-
Neutrogena® Unveils a New Acne Solution for Adults, Co‑Designed with Leading Dermatologists
-
Hyperliquid Strategies Inc Reports Financial Results for the Quarter Ended December 31, 2025
-
Avery Dennison Announces Upcoming Investor Events
-
Chimera Increases First Quarter 2026 Common Stock Dividend to $0.45 and Declares First Quarter 2026 Preferred Stock Dividends
-
New TELUS Digital Poll and Research Paper Find that AI Accuracy Rarely Improves When Questioned
-
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
-
Designer Brands Inc. Appoints Sheamus Toal as Chief Financial Officer
-
OneSpaWorld Announces Fourth Quarter Fiscal 2025 Financial Results on February 18, 2026
-
Ferguson to Issue Results for the Period Ended December 31, 2025, as well as provide an Update on Market Opportunities and Strategy on February 24, 2026
-
Innospec Fuel Specialties Announces New Partnership With Africa Gifted Foundation to Advance Stem Education for Young Women
-
Einride Joins the European Connected and Autonomous Vehicle Alliance (ECAVA)
-
TotalEnergies SE: Fourth Quarter and Full Year 2025 Results
-
Centrus and Fluor Partner to Advance Major Expansion of Ohio Uranium Enrichment Plant

